Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0348.HK Stock Summary
Top 10 Correlated ETFs
0348.HK
In the News
0348.HK Financial details
Company Rating
Neutral
Market Cap
29.28M
Income
-106.44M
Revenue
219.92M
Book val./share
0.14
Cash/share
0.08
Dividend
-
Dividend %
-
Employees
100
Optionable
No
Shortable
Yes
Earnings
26 Mar 2024
P/E
-0.61
Forward P/E
-
PEG
-0.97
P/S
0.21
P/B
0.24
P/C
0.49
P/FCF
-1.01
Quick Ratio
0.98
Current Ratio
3.68
Debt / Equity
1.04
LT Debt / Equity
0.73
-
-
EPS (TTM)
-0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-45.85%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.54%
Revenue last 5Y
-20.65%
Revenue Q/Q
100%
EPS Q/Q
100%
-
-
-
-
SMA20
-
SMA50
25%
SMA100
-16.67%
Inst Own
-
Inst Trans
-
ROA
-19%
ROE
-33%
ROC
-0.05%
Gross Margin
37%
Oper. Margin
-8%
Profit Margin
-38%
Payout
-
Shs Outstand
770.48M
Shs Float
605.02M
-
-
-
-
Target Price
-
52W Range
0.034-0.187
52W High
-
52W Low
-
RSI
38.94
Rel Volume
1.6
Avg Volume
431.89K
Volume
690K
Perf Week
-50.63%
Perf Month
-25%
Perf Quarter
-32.76%
Perf Half Y
-32.76%
-
-
-
-
Beta
0.374
-
-
Volatility
0%, 0.01%
Prev Close
8.33%
Price
0.039
Change
2.63%
0348.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-03-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.53 | 0.18 | 0.18 | 0.22 | 0.18 | |
Net income per share | -0.11 | -0.2 | -0.09 | -0.13 | -0.07 | |
Operating cash flow per share | -0.27 | 0.01 | 0.02 | 0.05 | -0.04 | |
Free cash flow per share | -0.28 | 0 | 0.01 | 0.05 | -0.04 | |
Cash per share | 0.29 | 0.22 | 0.18 | 0.13 | 0.09 | |
Book value per share | 0.54 | 0.4 | 0.38 | 0.25 | 0.18 | |
Tangible book value per share | 0.46 | 0.4 | 0.38 | 0.25 | 0.18 | |
Share holders equity per share | 0.54 | 0.4 | 0.38 | 0.25 | 0.18 | |
Interest debt per share | 0.15 | 0.33 | 0.17 | 0.13 | 0.15 | |
Market cap | 354.95M | 291.89M | 178.25M | 215.73M | 145.62M | |
Enterprise value | 414.32M | 383.64M | 257.23M | 266.59M | 238.67M | |
P/E ratio | -3.72 | -1.76 | -2.57 | -2.09 | -2.68 | |
Price to sales ratio | 0.79 | 2.03 | 1.29 | 1.27 | 1.03 | |
POCF ratio | -1.56 | 40.69 | 14.87 | 5.13 | -5.14 | |
PFCF ratio | -1.51 | 74.8 | 23.86 | 5.17 | -5.03 | |
P/B Ratio | 0.78 | 0.89 | 0.6 | 1.12 | 1.05 | |
PTB ratio | 0.78 | 0.89 | 0.6 | 1.12 | 1.05 | |
EV to sales | 0.92 | 2.67 | 1.87 | 1.57 | 1.68 | |
Enterprise value over EBITDA | 1.46K | -35.82 | 20.13 | 8.59 | -31.05 | |
EV to operating cash flow | -1.82 | 53.48 | 21.45 | 6.33 | -8.42 | |
EV to free cash flow | -1.77 | 98.32 | 34.43 | 6.39 | -8.24 | |
Earnings yield | -0.27 | -0.57 | -0.39 | -0.48 | -0.37 | |
Free cash flow yield | -0.66 | 0.01 | 0.04 | 0.19 | -0.2 | |
Debt to equity | 0.25 | 0.74 | 0.38 | 0.47 | 0.79 | |
Debt to assets | 0.16 | 0.4 | 0.26 | 0.29 | 0.38 | |
Net debt to EBITDA | 209.76 | -8.57 | 6.18 | 1.64 | -12.11 | |
Current ratio | 2.96 | 2.07 | 5.73 | 1.69 | 3.68 | |
Interest coverage | -0.44 | -1.01 | 0.12 | 4.18 | -1.51 | |
Income quality | 2.14 | -0.05 | -0.45 | -0.42 | 0.5 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.18 | 0.29 | 0.25 | 0.19 | 0.27 | |
Research and developement to revenue | 0 | 0.02 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0.19 | |
Capex to operating cash flow | 0.03 | -0.46 | -0.38 | -0.01 | 0.02 | |
Capex to revenue | -0.02 | -0.02 | -0.03 | 0 | 0 | |
Capex to depreciation | -1.71 | -0.25 | -0.43 | -0.09 | -0.19 | |
Stock based compensation to revenue | 0.03 | 0.11 | 0 | 0 | 0 | |
Graham number | 1.17 | 1.36 | 0.88 | 0.87 | 0.53 | |
ROIC | -0.01 | -0.04 | 0 | 0.09 | -0.04 | |
Return on tangible assets | -0.14 | -0.28 | -0.16 | -0.33 | -0.23 | |
Graham Net | -0.03 | 0.2 | 0.13 | 0.05 | 0.08 | |
Working capital | 389.51M | 281M | 238.24M | 82.22M | 200.26M | |
Tangible asset value | 387.73M | 320.97M | 296.29M | 193.06M | 83.62M | |
Net current asset value | 284.01M | 272.82M | 150.6M | 80.83M | 126.01M | |
Invested capital | 0.25 | 0.74 | 0.38 | 0.47 | 0.79 | |
Average receivables | 0 | 147.83M | 197.41M | 70.96M | 93.23M | |
Average payables | 54.42M | 68.5M | 54.2M | 14.15M | 20.69M | |
Average inventory | 83.78M | 70.34M | 58.45M | 54.34M | 57.92M | |
Days sales outstanding | 0 | 750.08 | 262.51 | 91.82 | 369.15 | |
Days payables outstanding | 50.01 | 458.25 | 50.85 | 81.25 | 97.72 | |
Days of inventory on hand | 91.27 | 323.35 | 227.96 | 280.21 | 226.6 | |
Receivables turnover | 0 | 0.49 | 1.39 | 3.98 | 0.99 | |
Payables turnover | 7.3 | 0.8 | 7.18 | 4.49 | 3.74 | |
Inventory turnover | 4 | 1.13 | 1.6 | 1.3 | 1.61 | |
ROE | -0.21 | -0.51 | -0.23 | -0.53 | -0.39 | |
Capex per share | -0.01 | 0 | -0.01 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.04 | 0.09 | 0.05 | 0.1 | |
Net income per share | 0 | -0.03 | -0.05 | -0.02 | -0.04 | |
Operating cash flow per share | 0 | 0 | 0.01 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0.01 | 0 | 0 | |
Cash per share | 0 | 0.03 | 0.09 | 0.02 | 0.08 | |
Book value per share | 0 | 0.18 | 0.18 | 0.14 | 0.14 | |
Tangible book value per share | 0 | 0.18 | 0.18 | 0.14 | 0.14 | |
Share holders equity per share | 0 | 0.18 | 0.18 | 0.14 | 0.14 | |
Interest debt per share | 0 | 0.09 | 0.15 | 0.1 | 0.15 | |
Market cap | 0 | 166.42M | 145.62M | 110.18M | 62.41M | |
Enterprise value | 79.03M | 149.57M | 238.67M | 101.34M | 165.16M | |
P/E ratio | 0 | -2.13 | -0.93 | -1.73 | -0.49 | |
Price to sales ratio | 0 | 5.06 | 2.21 | 2.73 | 0.77 | |
POCF ratio | 0 | -155.9 | 34.44 | 724.86 | 205.29 | |
PFCF ratio | 0 | -121.88 | 37.05 | 746.97 | 208.38 | |
P/B Ratio | 0 | 1.2 | 1.05 | 1.03 | 0.58 | |
PTB ratio | 0 | 1.2 | 1.05 | 1.03 | 0.58 | |
EV to sales | 0 | 4.55 | 3.63 | 2.51 | 2.04 | |
Enterprise value over EBITDA | 0 | -9.59 | -8.94 | 55.09 | -7.44 | |
EV to operating cash flow | 0 | -140.12 | 56.45 | 666.68 | 543.3 | |
EV to free cash flow | 0 | -109.54 | 60.73 | 687.02 | 551.47 | |
Earnings yield | 0 | -0.12 | -0.27 | -0.14 | -0.51 | |
Free cash flow yield | 0 | -0.01 | 0.03 | 0 | 0 | |
Debt to equity | 0.61 | 0.51 | 0.79 | 0.69 | 1.04 | |
Debt to assets | 0.35 | 0.25 | 0.38 | 0.32 | 0.48 | |
Net debt to EBITDA | 0 | 1.08 | -3.49 | -4.81 | -4.63 | |
Current ratio | 1.74 | 3.68 | 3.68 | 4.54 | 4.54 | |
Interest coverage | 0 | 0 | -6.93 | 0 | -5.54 | |
Income quality | 0 | 0.05 | -0.11 | -0.01 | -0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.29 | 0.14 | 0.2 | 0.1 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0.19 | 0 | 0 | |
Capex to operating cash flow | 0 | 0.28 | -0.07 | -0.03 | -0.01 | |
Capex to revenue | 0 | -0.01 | 0 | 0 | 0 | |
Capex to depreciation | 0 | -0.3 | -0.15 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0.32 | 0.45 | 0.25 | 0.36 | |
ROIC | 0 | -0.08 | -0.11 | 0.01 | -0.12 | |
Return on tangible assets | 0 | -0.07 | -0.17 | -0.07 | -0.14 | |
Graham Net | 0 | -0.12 | 0.08 | -0.12 | 0.05 | |
Working capital | 94.62M | 200.26M | 200.26M | 172.53M | 172.53M | |
Tangible asset value | 177.73M | 138.65M | 83.62M | 107.09M | 107.09M | |
Net current asset value | 93.95M | 126.01M | 126.01M | 94.39M | 94.39M | |
Invested capital | 0.61 | 0.51 | 0.79 | 0.69 | 1.04 | |
Average receivables | 0 | 2.9M | 74.74M | 74.19M | 59.17M | |
Average payables | 0 | 15.15M | 23.77M | 14.93M | 6.08M | |
Average inventory | 0 | 47.66M | 55.12M | 48.95M | 42.78M | |
Days sales outstanding | 0 | 15.88 | 196.55 | 10.48 | 126.53 | |
Days payables outstanding | 0 | 67.03 | 54.79 | 23.21 | 11.6 | |
Days of inventory on hand | 0 | 155.44 | 127.05 | 163.23 | 81.61 | |
Receivables turnover | 0 | 5.67 | 0.46 | 8.59 | 0.71 | |
Payables turnover | 0 | 1.34 | 1.64 | 3.88 | 7.76 | |
Inventory turnover | 0 | 0.58 | 0.71 | 0.55 | 1.1 | |
ROE | 0 | -0.14 | -0.28 | -0.15 | -0.3 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
0348.HK Frequently Asked Questions
What is China Healthwise Holdings Limited stock symbol ?
China Healthwise Holdings Limited is a HK stock and trading under the symbol 0348.HK
What is China Healthwise Holdings Limited stock quote today ?
China Healthwise Holdings Limited stock price is $0.039 today.
Is China Healthwise Holdings Limited stock public?
Yes, China Healthwise Holdings Limited is a publicly traded company.